CVS Health Co. (NYSE:CVS) Shares Sold by Rockefeller Capital Management L.P.

Rockefeller Capital Management L.P. lessened its holdings in CVS Health Co. (NYSE:CVS) by 5.8% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 604,032 shares of the pharmacy operator’s stock after selling 36,941 shares during the period. Rockefeller Capital Management L.P.’s holdings in CVS Health were worth $37,997,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of CVS. Vinva Investment Management Ltd raised its holdings in CVS Health by 10.2% in the third quarter. Vinva Investment Management Ltd now owns 56,446 shares of the pharmacy operator’s stock valued at $3,465,000 after acquiring an additional 5,242 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in CVS Health by 1.6% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,049,945 shares of the pharmacy operator’s stock valued at $443,301,000 after buying an additional 107,977 shares during the last quarter. Public Sector Pension Investment Board raised its stake in CVS Health by 2.3% in the third quarter. Public Sector Pension Investment Board now owns 327,080 shares of the pharmacy operator’s stock valued at $20,567,000 after buying an additional 7,200 shares in the last quarter. Fiduciary Trust Co boosted its position in shares of CVS Health by 0.3% during the 3rd quarter. Fiduciary Trust Co now owns 108,151 shares of the pharmacy operator’s stock worth $6,801,000 after acquiring an additional 375 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of CVS Health by 3.7% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 261,194 shares of the pharmacy operator’s stock valued at $16,424,000 after acquiring an additional 9,418 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

CVS opened at $59.82 on Friday. CVS Health Co. has a 1-year low of $52.71 and a 1-year high of $83.25. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The stock’s 50 day simple moving average is $59.36 and its 200 day simple moving average is $58.74. The stock has a market cap of $75.28 billion, a P/E ratio of 15.18, a P/E/G ratio of 1.02 and a beta of 0.55.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.21 earnings per share. As a group, equities analysts anticipate that CVS Health Co. will post 5.37 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.45%. The ex-dividend date was Monday, October 21st. CVS Health’s payout ratio is 67.51%.

Analysts Set New Price Targets

Several equities research analysts recently commented on CVS shares. StockNews.com lowered shares of CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. Evercore ISI raised their target price on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Mizuho reduced their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. UBS Group raised their price objective on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research report on Thursday, November 7th. Finally, Barclays reduced their target price on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a report on Thursday, November 7th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $70.33.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.